SCHEMBL20736909

SCHEMBL20736909

c1ccc(-c2cccc(-c3ccc(-c4ccc5cc6c(cc5c4)C4(c5ccccc5-c5ccccc54)c4ccc5ccccc5c4-6)cc3)n2)nc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 2/20 0.37
KDM4E B2RXH2 4/20 0.36
TP53 P04637 4/20 0.36
SMN1; SMN2 Q16637 4/20 0.36
LMNA P02545 2/20 0.36
MAPK1 P28482 2/20 0.36
CCR1 P32246 2/20 0.36
CCR5 P51681 2/20 0.36
CCR8 P51685 2/20 0.36
ALPL P05186 1/20 0.36
HSP90AA1 P07900 1/20 0.36
ALPI P09923 1/20 0.36
ALPG P10696 1/20 0.36
ALOX15 P16050 1/20 0.36
HTT P42858 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
ALDH1A1 P00352 3/20 0.34
MAPT P10636 3/20 0.34
HSD17B10 Q99714 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20736913 0.96 PDK2 (0.41) PDK2KDM4ETP53SMN1; SMN2LMNA
SCHEMBL20737135 0.95 PDK2 (0.39) PDK2KDM4ETP53SMN1; SMN2LMNA
SCHEMBL27250530 0.95 PDK2 (0.41) PDK2KDM4ETP53SMN1; SMN2LMNA
SCHEMBL20737127 0.92 PDK2 (0.37) PDK2KDM4ETP53SMN1; SMN2LMNA
SCHEMBL27250543 0.91 PDK2 (0.38) PDK2KDM4ETP53SMN1; SMN2LMNA
SCHEMBL27250541 0.90 PDK2 (0.37) PDK2KDM4ETP53SMN1; SMN2LMNA
SCHEMBL20735880 0.90 KDM4E (0.43) PDK2KDM4ETP53SMN1; SMN2LMNA
SCHEMBL27250565 0.87 PDK2 (0.39) PDK2KDM4ETP53SMN1; SMN2LMNA
SCHEMBL27250535 0.87 KDM4E (0.31) PDK2KDM4ETP53SMN1; SMN2LMNA
SCHEMBL20736073 0.87 PDK2 (0.40) PDK2KDM4ETP53SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12022728-B2 Organic electroluminescent element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2024-06-25 US disclosed
US-11552251-B2 Organic electroluminescent element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-01-10 US disclosed
US-20190051835-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2019-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11552251-B2 Organic electroluminescent element and electronic device L1CAM, ESR1, LEF1 PDK2 2420/4885KDM4E 2169/4885TP53 3684/4885
US-20190051835-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE L1CAM, ESR1, LEF1 PDK2 2420/4885KDM4E 2169/4885TP53 3684/4885
US-12022728-B2 Organic electroluminescent element and electronic device L1CAM, ESR1, LEF1 PDK2 2420/4885KDM4E 2169/4885TP53 3684/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.